ViroPharma Reviews

4.4
7 Reviews
Rating Trends
Recommend to a friend
Approve of CEO
ViroPharma President, CEO, CFO, and Director Vinnie Milano
Vinnie Milano
7 Ratings
  • Great company - family culture

    • Comp & Benefits
    • Work/Life Balance
    • Senior Management
    • Culture & Values
    • Career Opportunities
    Former Employee - Finance in Exton, PA
    Former Employee - Finance in Exton, PA

    I worked at ViroPharma

    Pros

    Great employee compensation and benefit packages

    Cons

    work-life balance needed some work

    Advice to ManagementAdvice

    cross department knowledge not readily shared

    Recommends
    Negative Outlook
    Approves of CEO

ViroPharma Interviews

Interview Experience

Interview Experience

0%
0%
100%

Getting an Interview

Getting an Interview

100%

Interview Difficulty

3.0
Average

Interview Difficulty

Hard

Average

Easy
  1.  

    CRA Interview

    Anonymous Interview Candidate
    Anonymous Interview Candidate
    Application Details

    I applied through a recruiter. The process took 4+ weeksinterviewed at ViroPharma in September 2009.

    Interview Details

    Very lengthy. Three rounds of interviews with multiple people each round.

    Interview Questions
    Negotiation Details
    They do not negotiate.
    Accepted Offer
    Negative Experience
    Average Interview

ViroPharma Awards & Accolades

Something missing? Add an award
Top Workplaces -- Midsize (#2), Philly.com, 2012
Best Places to Work in Pennsylvania (Small/Medium), Best Companies Group, 2008

Additional Info

Unlock Profile
Website www.viropharma.com
Headquarters Lexington, MA
Size 150 to 499 Employees
Founded 1994
Type Company - Public
Industry Biotech & Pharmaceuticals
Revenue $25 to $50 million (USD) per year

ViroPharma didn't want to wait until its drugs were finished to start making money, so instead it bought some already approved ones. The biopharmaceutical development firm discovers drugs to combat viral infections and other serious diseases. To finance its development, the company markets the antibiotic Vancocin for treating conditions of C. difficile, Staphylococcus aureus and other hospital-related infections. It also markets Cinryze, a drug made from human plasma to combat hereditary angiodema (HAE, a potentially fatal genetic disease that causes swelling of the skin... More

Work at ViroPharma? Share Your Experiences

ViroPharma

 
Click to Rate
or